Q&A
Q&A
December 27, 2011
J.K. WallDr. Bryan Schneider, a professor at the Indiana University School of Medicine, led a team of researchers in identifying genetic variations that dispose some breast cancer patients to neuropathy when they are receiving chemotherapy with the drug Taxol. Schneider’s research was named one of the biggest advances in cancer research this year by the American Society of Clinical Oncology. The society’s foundation also gave Schneider a three-year, $450,000 grant to further the research.
Q&A
December 5, 2011
J.K. WallCarmel resident David Wasilewski has launched WhatNext, a website that uses algorithms to make it easier
for cancer patients to connect with others in similar circumstances. Wasilewski, 39, spent eight years as chief operating
officer of the Spanx line of body shapers and did health care consulting before that. In addition to helping patients, he
thinks WhatNext can become a way for health care organizations share their expertise with patients in need.
MoreQ&A
October 17, 2011
J.K. WallSherry Keramidas, who earned her doctorate in neuroscience and physiological psychology from Purdue University,
is executive director of the Maryland-based Regulatory Affairs Professionals Society, which is holding its annual conference
Oct. 22-26 at the Indiana Convention Center.
MoreQ&A
September 26, 2011
J.K. WallDr. Ed Kowlowitz, owner and medical director of the Center for Pain Management in Indianapolis, recently
challenged a regional Medicare reimbursement policy and, surprisingly, won. He spoke with IBJ about the experience,
as well how his three-physician practice is growing even while many physician practices are selling to hospitals.
MoreDemographic shift steers Lilly's Asian operations
March 26, 2011
Greg AndrewsChina remains a small market for Eli Lilly and Co. It generated $320 million in sales for the company in 2010, just 1.3 percent
of its $23 billion in sales worldwide. But Lilly has big ambitions in China and is racing to capitalize on its rapid economic
growth.
MoreQ&A
December 8, 2010
J.K. WallMolecular biologist,David G. Skalnik will become associate dean for research and graduate education at the
IUPUI School of Science in January. Since 1991, Skalnick has been a researcher at the Indiana University School of Medicine,
leading a team of three in the study of epigenetics—factors that influence whether certain genes are turned on or turned
off.
MoreQ&A: Jim Hamilton
November 3, 2010
J.K. WallJim Hamilton, an employee-benefits lawyer at Bose McKinney & Evans in Indianapolis, discussed the likelihood
of a Republican-controlled U.S. House of Representatives changing or even outright repealing the health care reform law, formally
known as the Patient Protection and Affordable Care Act.
MoreFormer IU tech-transfer chief: State isn't competitive enough
October 30, 2010
Norm HeikensMark Long was president of the Indiana University Research & Technology Corp., which was responsible for the university’s
tech transfer, before launching a consulting firm, Long Performance Advisors, in 2008.
MoreQ&A: Don Stumpp
May 26, 2010
J.K. WallDon Stumpp, manager of payer contracting at Indianapolis-based physician group American Health Network and president of the
Indiana Medical Group Management Association, discussed the impact of the health care reform law on primary care physicians
as well as the near-constant threat of a sharp cut in Medicare reimbursement.
MoreDean of IU's Indianapolis law school hopes to end campus confusion
May 15, 2010
Norm HeikensJust about everyone thinks the Indianapolis law school is a branch of the one in Bloomington. It isn't, and Gary Roberts
says
confusion reigns as a result.
MoreQ&A: Jim Parker
April 14, 2010
J.K. WallJim Parker was an executive at Anthem Blue Cross and Blue Shield and WellPoint for 14 years, including a year and a half as
chief of staff to CEO Angela Braly. He now is president of his own consulting firm, Meridian Strategic Advisors, in Indianapolis.
He spoke about the impact of the new health reform law on health insurers.
MoreQ&A: Dr. John Fitzgerald
February 17, 2010
J.K. WallThe Indiana Clinic, launched about a year ago, has signed 412 physicians as employees, and is still working
toward a goal of as many as 1,500 by 2011. The clinic, a joint venture of Clarian Health and the Indiana University
School of Medicine, is headed by Dr. John Fitzgerald. He discussed the progress.
MoreHealth care Q&A: Greg Pemberton
January 20, 2010
J.K. WallGreg Pemberton, a health care attorney at Ice Miller LLP, discussed the biggest changes he expects to come out of the federal
health reform bills. “It’s not going to be business as usual,” he said.
MoreQ&A with Indianapolis Airport Authority CEO John Clark
August 17, 2009
Chris O'MalleyClark talks to IBJ about how the airport can increase revenue by diversifying its sources of income. The airport can't rely
on higher passenger counts to boost its bottom line.
MoreNew Speedway boss Jeff Belskus: 'We do face some challenges'
August 10, 2009
Anthony SchoettleNew Speedway leader Jeff Belskus speaks with IBJ about his new job and the near-term challenges and long-term future of the
operations he oversees.
MoreNew higher-ed chief takes aim at dropout rates
August 3, 2009
J.K. WallTeresa Lubbers became Indiana commissioner for higher education on July 7 after serving 17 years as a Republican state
senator from Indianapolis. She says every Hoosier needs some college-level training. Lubbers got a running start on her new
job, having served as chairwoman of the senate education committee
for years. She also worked frequently at the commission’s downtown offices during May and June—after her predecessor
had
left but before the Legislature returned for a special session to pass a budget. Her new staff dubbed her SenComm.
MorePeterson has passion for health care and new Lilly position
June 29, 2009
J.K. WallA new communications post at Eli Lilly gives former mayor Bart Peterson an opportunity to meld his experiences in the public
and private sectors.
MoreBennett draws up education game plan
April 20, 2009
J.K. WallIndiana's superintendent of public instruction stresses reading, math and competition.
MoreNew Community CEO weighs in on system's future, universal care
April 6, 2009
J.K. WallIBJ reporter J.K. Wall asked Bryan A. Mills about his new job as Community Health Networks next CEO.
PNC plans return to 'old-fashioned' lending standards
March 2, 2009
Peter SchnitzlerPNC CEO James Rohr, 60, recently sat down with IBJ to discuss the merger between PNC
Financial Services Group Inc. and National City Corp., as well as the recession and PNC's strategy.
MoreLyon takes Finish Line helm as shoppers cut spending
February 2, 2009
Cory SchoutenGlenn S. Lyon, the new head at The Finish Line Inc., has plenty to tackle. Traffic is down at Finish Line stores, sales have
slowed and competitors are slashing prices.
MoreGrants will shrink, life sciences leader predicts
January 19, 2009
Scott OlsonLast fall, BioCrossroads named Leonard J. Betley—chairman of the Richard M. Fairbanks Foundation, the Regenstrief Foundation
and the Walther Cancer Foundation—its inaugural Life Sciences Champion of the Year. IBJ
recently caught up with Betley to get his thoughts on the latest life sciences developments and gauge the climate
for fund raising.
MoreAs Indiana's commerce chief, Roob aims to 'hit on all cylinders'
January 12, 2009
Peter SchnitzlerIBJ talked to new Secretary of Commerce Mitch Roob about Indiana's challenges in 2009, including a recessionary economy, rising
unemployment
and work-force training gaps.
MoreConseco's investment loss of $96 million 'pretty good' by comparison
December 22, 2008
J.K. WallEric Johnson, Conseco Inc.'s president over its investment unit called 40/86 Advisors, talked with IBJ about the surprises
of the investing world over the last 18 months.
MoreFranchises can be safer business investments in tough times
December 15, 2008
Scott OlsonWhat is the current state of franchising, given the tough economic environment?
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
IBJ Featured Advertisers
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Maybe they should have sold the naming rights to the new airport terminal, instead of giving it away for nothing to honor some obscure politician.
Rolls Royce Terminal sounds nice, and $10 million a year licensing fee sounds pretty good right now.
The old airport terminal was a complete dump that was a patchwork of "fixes" over the decades with a confusing and frustrating maze of roads leading to it.
The new airport terminal is well worth it.
It is the first and last impression anyone coming from any real distance remembers of our community.
It is an essential service that is used everyday, unlike the $750 million football stadium.
Nothing like putting on the Ritz.
Flipsides Pretzel Crackers
The new airport was a waste of money and it was a "legacy" project for Bart Peterson. BAA, the former airport operator, did a complete study showing that if the airport spent $275 million on the old terminal, the airport would be better positioned for the future, financially. Bart Peterson and Melina Kennedy felt differently and with the help of Patrick Dooley, then airport director, they set out in spending the money to build the new terminal. No taxpayer money is used to operate the airport, but we all pay for the new and old airport facilities through higher fees.